We had positive PCR results in 13.2% of adenoid samples in cases (mean age = 6.8) but in none of the controls (P = 0.05). The condition was more prevalent in warmer seasons (spring & summer = 5/7; P = 0.05). Although, based on our findings, recent infection (positive IgM) was seen twice as frequently in cases, but it still was of no significance (11% vs 6.5%, P = 0.7). Positive IgG (previous immunity) was detected in none of the cases (0.51) and 13.3% of the controls, without any significant difference (P = 0.007), suggesting that patients in the study group did not have a C. pneumoniae infection history and thus, the immunity against it. Finding IgM in the sera correlated well with positive PCR results in the cases. The results of the study showed a positive correlation between PCR and serology (IgM) results in the case group.
The positive correlation between PCR and IgM test results indicates the probable role of recent C. pneumoniae infection in at least 13% of cases with adenoid hypertrophy. None of the studied cases showed previous immunity (positive IgG) against C. pneumoniae, however, 13.3% of controls were immune to the disease (P = 0.007). It is not unreasonable to assume that Iranian children get infected with C. pneumoniae between the ages of 6-8 and thus, get immune against C. pneumoniae. In fact, the absence of a protective immunity in some infected cases leads to organism reservation in the adenoid tissue and rhinosinusitis concomitant with adenoid hypertrophy. For the diagnosis of C. pneumoniae infection, culture is the gold standard diagnostic method. However, C. pneumoniae culture is not considered as the optimal method due to limitations like slow growth, technical difficulty and limited viability of the bacteria.
Serological tests are the most common methods for of
C. pneumoniae infection Diagnosis. Detection of
C. pneumoniae–specific antibodies is also possible by micro immuno fluorescence, ELISA and EIA. As recommended by disease control and prevention centers, for acute
C. pneumoniae infection diagnosis, a single IgM titer of greater than or equal to 1:64 or a fourfold increase in the IgG titer in acute and convalescent serum, measured 4 weeks apart from each other, is enough. The use of single IgG or IgA titers is discouraged due to their relatively high overall seroprevalence in healthy populations (
4,
5,
9).
Positive PCR results in the present study were two times higher than those reported by Normann et al. (7%) (
10) and 5% Cultrara et al. (5%) (
6), but very lower than in children with pneumonia (
14). Cultrara et al. did not isolate
C. pneumoniae from sinus specimens in children, with the use of sensitive culture methods (
6). According to Volanen et al. (
15)
C. pneumoniae infection probably occurs at an early age, asymptomatically, resulting in the consecutive high IgG and IgA antibody concentrations at the ages of seven and eight years. Multiple Iranian studies (using serology and PCR methods) defined a higher incidence of
C. pneumoniae infections in respiratory tracts.
The incidence of
C. pneumoniae in our population is higher than that of the developed countries (
11,
16).
C. pneumoniae played a prominent role in pediatric
C. pneumoniae (mean age of 3.8 years) (
13). Most of the children were seropositive (IgG) at the age of five. The previous immunity (IgG) was present in 57% of children with pneumonia but had similar results in cases and controls. Recent
C. pneumoniae infection (IgM) was significantly higher in pneumonia cases (P > 0.001) (
13).
C. pneumoniae is a common respiratory pathogen in our pediatric populations (< 5 years).
C. pneumoniae can occur commonly at an early age, often asymptomatically but may colonize in the adenoid tissue in children. (
12,
13).
C. pneumoniae was also separated from nasal polyps in adult cases (
14).
In recent years, a new role was reported for
C. pneumoniae in asthma exacerbation, in North east of Iran (
16).
C. pneumoniae was separated from 7.6% of nasopharyngeal epithelial cell cultures of patients with asthma exacerbation and 35% of patients with chronic stable asthma and from 14.3% and 5% of their control groups, respectively. Successful eradication of
C. pneumoniae was accompanied with clinical improvement (
16). Most studies performed in Iran, except for one study, detected
C. pneumoniae infection by serological tests and PCR or cultures were not used to confirm the active
C. pneumoniae infection (
16). Using the most sensitive culture methods, Piacentini et al. (
8) were not able to isolate
C. pneumoniae from sinus specimens of children. Due to the higher sensitivity of PCR for
C. pneumoniae detection, in comparison with serological tests, detection of DNA in adenoid tissues would exaggerate and magnify even the smallest differences between the two groups.
Theoretically, the use of suitable antibiotics to eradicate the C. pneumoniae, before performing adenoid surgery in cases with rhinosinusitis might be helpful. However, it needs further randomized controlled trials before being approved as a treatment measure. The positive PCR and serological (IgM) tests proved the existence of recent C. pneumoniae infection in patients undergoing adenoidectomy. None of these patients had any sign of previous immunity, unlike the controls. All these findings indicate the probable role of C. pneumoniae infection in adenoid hypertrophy in nearly 13% of cases. In our opinion adenoid tissue might act as a reservoir for C. pneumoniae and cause rhinosinusitis concomitant with adenoid hypertrophy in infected children. To establish the effect of suitable antibiotics in C. pneumoniae eradication, before submitting for adenoidectomy, needs more randomized clinical trials in the future.